From Deseret News archives:

Cancer drug may double as an arthritis treatment

Published: Wednesday, March 1, 2006 9:50 p.m. MST
 |  E-MAIL | PRINT | FONT + - 
WASHINGTON (AP) — The nation's best-selling cancer drug has won federal approval as a treatment for rheumatoid arthritis patients for whom other, older drugs don't work, Genentech Inc. and Biogen Idec Inc. said Wednesday.

The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's lymphoma.

The two companies said Rituxan should be used by patients who haven't had success with a class of rheumatoid arthritis drugs called tumor necrosis factor, or TNF, blockers. Those drugs include Enbrel, Remicade and Humira.

Comments

You can be the first to comment on this story.

previousnext

Latest comments

Utes finally get to host Michigan

Idaho? Weber State? Silence.

They are all self reporting. If a man describes an encounter as casual...

Many of these posts illustrate what a sad world we live in. The song is...

BoM translation remarkably consistent

I believe the BOM is historical. I begin with a spiritual confirmation. But...

Alpine, Nebo, and Provo districts worked together with other interested...

Todd: He could practice all day long with these guys but we all know it's NBA...

Panel passes BCS playoff bill

A lot of you are complaining about the "government having better things to...

Raids displease both sides

I'm still new to this whole thing, after all i am still only in high school....

Dishonest global warming scientists

won't do any good to read it if the original data is missing and the rest of...

How about those who actually aren't sexually active? What is their emotional...

Advertisements